Loading clinical trials...
Loading clinical trials...
Molecular Study of the Maternal-fetal Interface Prospectively to the Onset of Preeclampsia Using Single Cell Technology.
Conditions
Interventions
Maternal-fetal interface biopsy and peripheral blood collection in cases group
Maternal-fetal interface biopsy and peripheral blood collection in control group
Locations
5
Spain
Hospital General Universitario Dr. Balmis
Alicante, Alicante, Spain
Hospital Universitario de Torrejón
Madrid, Madrid, Spain
Hospital Clinico Universitario Virgen de la Arrixaca
Murcia, Murcia, Spain
Hospital Universitario de Canarias
Santa Cruz de Tenerife, Santa Cruz de Tenerife, Spain
Hospital Universitario y Politécnico La Fe
Valencia, Valencia, Spain
Start Date
November 20, 2023
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2027
Last Updated
April 13, 2026
NCT07485140
NCT06749418
NCT05999851
NCT07356817
NCT07282171
NCT06468202
Carlos Simón, MD, PhD
CONTACT
Lead Sponsor
Carlos Simon Foundation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions